je.st
news
Tag: completes phase
Cupertino Electric Completes First Phase of 21-Site Solar Project
2013-05-21 18:35:00| Electrical Construction & Maintenance
The Energy Alternatives Division of Cupertino Electric has completed the first phase of a parking lot canopy and playground shade structure-based solar system for California's Clovis Unified School District read more
Tags: project
phase
electric
solar
Boskalis-Van Oord JV completes first phase of Maasvlakte II
2013-04-19 01:00:00| Ship Technology
PUMA, a joint venture (JV) between Boskalis and Van Oord, has completed the first phase of the Maasvlakte II harbour expansion at the Port of Rotterdam in the Netherlands.
Tags: ii
phase
completes
completes phase
BEUMER Group's Crisplant Completes Phase 1 for the Baggage Handling System at El Dorado International Airport, Bogotá, Colombia
2013-04-09 17:37:00| Airport Technology
Crisplant, part of BEUMER Group and a leading global supplier of automated baggage handling systems, has successfully completed the first phase of contract for the design, manufacture and integration of energy-efficient, high-speed automated baggage
Tags: system
international
groups
phase
Biodel Completes Enrollment In Phase 2 Clinical Trial Of Ultra-Rapid-Acting Insulin Candidate BIOD-123 For The Treatment Of Diabetes
2013-03-28 09:57:29| dairynetwork Home Page
Biodel Inc. (Nasdaq:BIOD) today announced the completion of patient enrollment in a Phase 2 clinical study of ultra-rapid-acting prandial insulin candidate BIOD-123 for the treatment of diabetes. The trial will evaluate the use of BIOD-123 versus Humalog® on measures of HbA1c, postprandial glucose excursions, glycemic variability, hypoglycemic event rates and weight changes.
Biodel Completes Enrollment In Phase 2 Clinical Trial Of Ultra-Rapid-Acting Insulin Candidate BIOD-123 For The Treatment Of Diabetes
2013-03-28 09:57:29| dairynetwork News Articles
Biodel Inc. (Nasdaq:BIOD) today announced the completion of patient enrollment in a Phase 2 clinical study of ultra-rapid-acting prandial insulin candidate BIOD-123 for the treatment of diabetes. The trial will evaluate the use of BIOD-123 versus Humalog® on measures of HbA1c, postprandial glucose excursions, glycemic variability, hypoglycemic event rates and weight changes.
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] next »